18
Participants
Start Date
July 23, 2024
Primary Completion Date
March 4, 2026
Study Completion Date
December 24, 2027
Blinatumomab
Administered via CIVI
RECRUITING
Shanghai Children's Medical Center, Shanghai
RECRUITING
Children's Hospital of Soochow University, Suzhou
RECRUITING
The Second Hospital of Anhui Medical University, Hefei
RECRUITING
Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences, Tianjin
RECRUITING
Childrens Hospital of Chongqing Medical University, Chongqing
RECRUITING
Zhujiang Hospital of Southern Medical University, Guangzhou
Lead Sponsor
Amgen
INDUSTRY